Use of adenine-derived compounds for the treatment of lupus

Details Use of adenine-derived compounds for the treatment of lupus Use of adenine-derived compounds for the treatment of lupus

A - Human Necessities

61

K

A61K 31/52 (2006.01) A61P 37/00 (2006.01)

Patent

CA 2645093

The invention relates to the use of adenine-derived compounds substituted in the 2- and 9-positions and, optionally, in the N(6)-position of the adenine, for the manufacture of a medicament for use in the treatment of systemic lupus erythematosus (SLE). The compounds can also be used in combination with a second compound used in the treatment of SLE.

L'invention concerne l'utilisation de composés dérivés de l'adénine, substitués en positions 2 et 9, et éventuellement N(6) de l'adénine, pour la fabrication d'un médicament destiné au traitement du lupus érythémateux disséminé (LED). Les composés peuvent également être utilisés en association avec un deuxième composé utilisé dans le traitement du LED.

Affiliated with

Also associated with

Rating

Use of adenine-derived compounds for the treatment of lupus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of adenine-derived compounds for the treatment of lupus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of adenine-derived compounds for the treatment of lupus will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2010160